VIVS logo

VivoSim Labs, Inc.

VIVS
Healthcare|Biotechnology|US
$0.14
+0.00 (+0.07%)
DCF Value
$1.67
Cash / Share
$0.32

Ownership Breakdown

83.4%
Float
16.6M
Shares Outstanding
13.8M
Float Shares

Major Holders (2)

Combined: 19.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Esousa Group Holdings LLCOther9.90%319,429Aug 17, 202613D/G
Michael WachsIndividual9.90%319,429Aug 17, 202613D/G

Insider Trades (11)

Last 4 quarters: 181,766 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Lialin Tony SergeChief Commercial OfficerAug 31, 2026BUY10,000$0.28$2.8KForm 4
Cohen Douglas JaydirectorJan 27, 2026AWARD15,000——Form 4
Murphy Keithdirector, officer: EXECUTIVE CHAIRMANJan 27, 2026AWARD15,000——Form 4
Milhous Alison TjosvolddirectorJan 27, 2026AWARD15,000——Form 4
Gobel DaviddirectorJan 27, 2026AWARD15,000——Form 4
STERN ADAM KdirectorJan 27, 2026AWARD15,000——Form 4
Sethi Amar AkhtarChief Scientific OfficerNov 25, 2025AWARD53,500$2.19$117.2KForm 4
Sethi Amar AkhtarNov 24, 2025OTHER0——Form 4
Gobel DaviddirectorNov 17, 2025SELL3,266$2.24$7.3KForm 4
Lialin Tony SergeChief Commercial OfficerAug 11, 2025AWARD40,000$1.78$71.2KForm 4
Lialin Tony SergeAug 11, 2025OTHER0——Form 4